Brain Fos expression induced by the chemotherapy agent cisplatin in the rat is partially dependent on an intact abdominal vagus

Autonomic Neuroscience: Basic and Clinical

Volumn 148, Issue 1-2, 2009, Pages 76-82

  Horn, Charles C ^a  

^a MONELL CHEMICAL SENSES CENTER   (United States)

Author keywords

Emesis; Fos; Nausea; Pica; Vagus

Indexed keywords

CISPLATIN; PROTEIN FOS;

ABDOMEN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOLITARY TRACT NUCLEUS; TISSUE LEVEL; VAGOTOMY; VAGUS NERVE;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN; CELL COUNT; CISPLATIN; GENE EXPRESSION REGULATION; MALE; ONCOGENE PROTEINS V-FOS; RATS; RATS, SPRAGUE-DAWLEY; STILBAMIDINES; VAGOTOMY; VAGUS NERVE;

EID: 67349149008     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2009.03.008     Document Type: Article

References (69)

1. Aapro M.S. How do we manage patients with refractory or breakthrough emesis?. Support. Care. Cancer. 10 (2002) 106-109
2. Andrews P.L.R. Why do some animals lack a vomiting reflex?. Physiol. Zool. 68 (1995) 61
3. Andrews P.L.R., and Rudd J.A. The role of tachykinins and the tachykinin NK1 receptor in nause and emesis. In: Holzer P. (Ed). Tachykinins (Handbook of Experimental Pharmacology vol. 164 (2004), Springer, Berlin 359-440
4. Andrews P.L., and Horn C.C. Signals for nausea and emesis: implications for models of upper gastrointestinal diseases. Auton. Neurosci. 125 (2006) 100-115
5. Andrews P.L., Davis C.J., Bingham S., Davidson H.I., Hawthorn J., and Maskell L. The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can. J. Physiol. Pharmacol. 68 (1990) 325-345
6. Ariumi H., Saito R., Nago S., Hyakusoku M., Takano Y., and Kamiya H. The role of tachykinin NK-1 receptors in the area postrema of ferrets in emesis. Neurosci. Lett. 286 (2000) 123-126
7. De Jonghe B.C., and Horn C.C. Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R756-765
8. De Jonghe B.C., and Horn C.C. Chemotherapy agent cisplatin induces 48 h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus). American Journal of Physiology (Regulatory, Integrative, and Comparative Physiology). 296 (2009) R902-R911
9. De Jonghe B.C., Lawler M.P., Horn C.C., and Tordoff M.G. Pica as an adaptive response: kaolin consumption helps rats recover from chemotherapy-induced illness. Physiology and Behavior 97 (2009) 87-90
10. de Olmos J.S., and Heimer L. The concepts of the ventral striatopallidal system and extended amygdala. Ann. N. Y. Acad. Sci. 877 (1999) 1-32
11. Endo T., Minami M., Nakayasu M., Hirafuji M., Hamaue N., Omae N., Kang Y., and Iwanaga T. Effects of granisetron and vagotomy on c-fos mRNA expression in the rat medulla oblongata as assessed by in situ hybridization. Biomed. Res. 25 (2004) 229-235
12. Garcia-Medina N.E., Jimenez-Capdeville M.E., Ciucci M., Martinez L.M., Delgado J.M., and Horn C.C. Conditioned flavor aversion and brain Fos expression following exposure to arsenic. Toxicology 235 (2007) 73-82
13. Grelot L., and Miller A.D. Vomiting-its ins and outs. News Physiol. Sci. 9 (1994) 142-147
14. Hainsworth J.D., and Hesketh P.J. Single-dose ondansetron for the prevention of cisplatin-induced emesis: efficacy results. Semin. Oncol. 19 (1992) 14-19
15. Heimer L., and Van Hoesen G.W. The limbic lobe and its output channels: implications for emotional functions and adaptive behavior. Neurosci. Biobehav. Rev. 30 (2006) 126-147
16. Higa G.M., Auber M.L., Altaha R., Piktel D., Kurian S., Hobbs G., and Landreth K. 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy. J. Oncol. Pharm. Pract. 12 (2006) 201-209
17. Higgins G.A., Kilpatrick G.J., Bunce K.T., Jones B.J., and Tyers M.B. 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br. J. Pharmacol. 97 (1989) 247-255
18. Hillsley K., and Grundy D. Plasticity in the mesenteric afferent response to cisplatin following vagotomy in the rat. J. Auton. Nerv. Syst. 76 (1999) 93-98
19. Horn C.C. Why is the neurobiology of nausea and vomiting so important?. Appetite 50 (2008) 430-434
20. Horn C.C., and Mitchell J.C. Does selective vagotomy affect conditioned flavor-nutrient preferences in rats?. Physiol. Behav. 59 (1996) 33-38
21. Horn C.C., Addis A., and Friedman M.I. Neural substrate for an integrated metabolic control of feeding behavior. Am. J. Physiol. 276 (1999) R113-119
22. Horn C.C., Tordoff M.G., and Friedman M.I. Role of vagal afferent innervation in feeding and brain Fos expression produced by metabolic inhibitors. Brain. Res. 919 (2001) 198-206
23. Horn C.C., Richardson E.J., Andrews P.L., and Friedman M.I. Differential effects on gastrointestinal and hepatic vagal afferent fibers in the rat by the anti-cancer agent cisplatin. Auton. Neurosci. 115 (2004) 74-81
24. Horn C.C., Ciucci M., and Chaudhury A. Brain Fos expression during 48 h after cisplatin treatment: neural pathways for acute and delayed visceral sickness. Auton. Neurosci. 132 (2007) 44-51
25. Huang A.C., and Hsiao S. Re-examination of amphetamine-induced conditioned suppression of tastant intake in rats: the task-dependent drug effects hypothesis. Behav. Neurosci. 122 (2008) 1207-1216
26. Jeggo R.D., Kellett D.O., Wang Y., Ramage A.G., and Jordan D. The role of central 5-HT3 receptors in vagal reflex inputs to neurones in the nucleus tractus solitarius of anaesthetized rats. J. Physiol. 566 (2005) 939-953
27. Kilpatrick G.J., Jones B.J., and Tyers M.B. Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur. J. Pharmacol. 159 (1989) 157-164
28. Kraly F.S., Jerome C., and Smith G.P. Specific postoperative syndromes after total and selective vagotomies in the rat. Appetite 7 (1986) 1-17
29. Kris M.G., Gralla R.J., Clark R.A., Tyson L.B., and Groshen S. Control of chemotherapy-induced diarrhea with the synthetic enkephalin BW942C: a randomized trial with placebo in patients receiving cisplatin. J. Clin. Oncol. 6 (1988) 663-668
30. Kris M.G., Hesketh P.J., Somerfield M.R., Feyer P., Clark-Snow R., Koeller J.M., Morrow G.R., Chinnery L.W., Chesney M.J., Gralla R.J., and Grunberg S.M. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J. Clin. Oncol. 24 (2006) 2932-2947
31. Litterst C.L., LeRoy A.F., and Guarino A.M. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals. Cancer. Treat. Rep. 63 (1979) 1485-1492
32. Liu Y.L., Malik N., Sanger G.J., Friedman M.I., and Andrews P.L. Pica-a model of nausea? Species differences in response to cisplatin. Physiol. Behav. 85 (2005) 271-277
33. Malik N.M., Moore G.B., Smith G., Liu Y.L., Sanger G.J., and Andrews P.L. Behavioural and hypothalamic molecular effects of the anti-cancer agent cisplatin in the rat: a model of chemotherapy-related malaise?. Pharmacol. Biochem. Behav. 83 (2006) 9-20
34. Malik N.M., Liu Y.L., Cole N., Sanger G.J., and Andrews P.L. Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats. Eur. J. Pharmacol. 555 (2007) 164-173
35. McCarthy L.E., and Borison H.L. Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats. Cancer. Treat. Rep. 68 (1984) 401-404
36. Miller A.D., Jakus J., and Nonaka S. Plasticity of emesis to a 5-HT3 agonist: effect of order of visceral nerve cuts. Neuroreport 5 (1994) 986-988
37. Miller A.D., and Ruggiero D.A. Emetic reflex arc revealed by expression of the immediate-early gene c-fos in the cat. J. Neurosci. 14 (1994) 871-888
38. Nelson K., Walsh D., and Sheehan F. Cancer and chemotherapy-related upper gastrointestinal symptoms: the role of abnormal gastric motor function and its evaluation in cancer patients. Support. Care. Cancer. 10 (2002) 455-461
39. Niedringhaus M., Jackson P.G., Evans S.R., Verbalis J.G., Gillis R.A., and Sahibzada N. Dorsal motor nucleus of the vagus: a site for evoking simultaneous changes in crural diaphragm activity, lower esophageal sphincter pressure, and fundus tone. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R121-131
40. Niedringhaus M., Jackson P.G., Pearson R., Shi M., Dretchen K., Gillis R.A., and Sahibzada N. Brainstem sites controlling the lower esophageal sphincter and crural diaphragm in the ferret: a neuroanatomical study. Auton. Neurosci. 144 (2008) 50-60
41. Norgren R., and Smith G.P. Central distribution of subdiaphragmatic vagal branches in the rat. J. Comp. Neurol. 273 (1988) 207-223
42. Olson B.R., Hoffman G.E., Sved A.F., Stricker E.M., and Verbalis J.G. Cholecystokinin induces c-fos expression in hypothalamic oxytocinergic neurons projecting to the dorsal vagal complex. Brain. Res. 569 (1992) 238-248
43. Pacak K., and Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr. Rev. 22 (2001) 502-548
44. Parker L.A. Rewarding drugs produce taste avoidance, but not taste aversion. Neurosci. Biobehav. Rev. 19 (1995) 143-157
45. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 5th ed. (2005), Elsevier Academic Press, Amsterdam San Diego, CA, USA.
46. Phifer C.B., and Berthoud H.R. Duodenal nutrient infusions differentially affect sham feeding and Fos expression in rat brain stem. Am. J. Physiol. 274 (1998) R1725-1733
47. Phillips T.D. Dietary clay in the chemoprevention of aflatoxin-induced disease. Toxicol. Sci. 52 (1999) 118-126
48. Phillips R.J., and Powley T.L. Gastric volume detection after selective vagotomies in rats. Am. J. Physiol. 274 (1998) R1626-1638
49. Phillips T.D., Sarr A.B., and Grant P.G. Selective chemisorption and detoxification of aflatoxins by phyllosilicate clay. Nat. Toxins. 3 (1995) 204-213 discussion 221
50. Qin C., Chen J.D., Zhang J., and Foreman R.D. Duodenal afferent input converges onto T9-T10 spinal neurons responding to gastric distension in rats. Brain. Res. 1186 (2007) 180-187
51. Rabin B.M., and Hunt W.A. Relationship between vomiting and taste aversion learning in the ferret: studies with ionizing radiation, lithium chloride, and amphetamine. Behav. Neural. Biol. 58 (1992) 83-93
52. Ranson R.N., Butler P.J., and Taylor E.W. The central localization of the vagus nerve in the ferret (Mustela putorius furo) and the mink (Mustela vison). J. Auton. Nerv. Syst. 43 (1993) 123-137
53. Reynolds D.J., Barber N.A., Grahame-Smith D.G., and Leslie R.A. Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694). Brain. Res. 565 (1991) 231-236
54. Rinaman L., and Schwartz G. Anterograde transneuronal viral tracing of central viscerosensory pathways in rats. J. Neurosci. 24 (2004) 2782-2786
55. Rudd J.A., and Andrews P.L.R. Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies. Management of nausea and vomiting in cancer and cancer treatment (2005) 15-65
56. Rudd J.A., Ngan M.P., and Wai M.K. 5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin. Eur. J. Pharmacol. 352 (1998) 143-149
57. Rudd J.A., Yamamoto K., Yamatodani A., and Takeda N. Differential action of ondansetron and dexamethasone to modify cisplatin-induced acute and delayed kaolin consumption ("pica") in rats. Eur. J. Pharmacol. 454 (2002) 47-52
58. Saeki M., Sakai M., Saito R., Kubota H., Ariumi H., Takano Y., Yamatodani A., and Kamiya H. Effects of HSP-117, a novel tachykinin NK1-receptor antagonist, on cisplatin-induced pica as a new evaluation of delayed emesis in rats. Jpn. J. Pharmacol. 86 (2001) 359-362
59. Sagar S.M., Sharp F.R., and Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240 (1988) 1328-1331
60. Sam T.S., Cheng J.T., Johnston K.D., Kan K.K., Ngan M.P., Rudd J.A., Wai M.K., and Yeung J.H. Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew). Eur. J. Pharmacol. 472 (2003) 135-145
61. Sharp F.R., Sagar S.M., Hicks K., Lowenstein D., and Hisanaga K. c-fos mRNA, Fos, and Fos-related antigen induction by hypertonic saline and stress. J. Neurosci. 11 (1991) 2321-2331
62. Swanson L.W. The amygdala and its place in the cerebral hemisphere. Ann. N. Y. Acad. Sci. 985 (2003) 174-184
63. Takeda N., Hasegawa S., Morita M., and Matsunaga T. Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol. Biochem. Behav. 45 (1993) 817-821
64. Takeda N., Hasegawa S., Morita M., Horii A., Uno A., Yamatodani A., and Matsunaga T. Neuropharmacological mechanisms of emesis. II. Effects of antiemetic drugs on cisplatin-induced pica in rats. Methods. Find. Exp. Clin. Pharmacol. 17 (1995) 647-652
65. Traub R.J., Sengupta J.N., and Gebhart G.F. Differential c-fos expression in the nucleus of the solitary tract and spinal cord following noxious gastric distention in the rat. Neuroscience 74 (1996) 873-884
66. Van Sickle M.D., Oland L.D., Mackie K., Davison J.S., and Sharkey K.A. Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. Am. J. Physiol. Gastrointest. Liver. Physiol. 285 (2003) G566-576
67. Vera G., Chiarlone A., Martin M.I., and Abalo R. Altered feeding behaviour induced by long-term cisplatin in rats. Auton. Neurosci. 126-127 (2006) 81-92
68. Watson Jr. R.E., Wiegand S.J., Clough R.W., and Hoffman G.E. Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 7 (1986) 155-159
69. Won M.H., Matsuo K., Oh Y.S., and Kitoh J. Brainstem topology of the vagal motoneurons projecting to the esophagus and stomach in the house musk shrew, Suncus murinus. J. Auton. Nerv. Syst. 68 (1998) 171-181